Data set name
|
Source Site
|
GEO Accession
|
Affymetrix platform
|
Sample size
|
---|
TCGA Ovarian Cancer
|
The Cancer Genome Atlas
| |
HT_HG-U133Aa
|
377
|
CCR Ovarian Cancer
|
Gene Expression Omnibus
|
GSE9891
|
HG-U133_Plus_2b
|
285
|
CCR Colon Cancer
|
Gene Expression Omnibus
|
GSE14333
|
HG-U133_Plus_2
|
290
|
Moffitt Colon Cancer
|
Gene Expression Omnibus
|
GSE17536
|
HG-U133_Plus_2
|
177
|
Singapore Gastric Cancer
|
Gene Expression Omnibus
|
GSE15459
|
HG-U133_Plus_2
|
200
|
CCR Breast Cancer
|
Gene Expression Omnibus
|
GSE7390
|
HG-U133Ac
|
198
|
Wang Breast Cancer
|
Gene Expression Omnibus
|
GSE2034
|
HG-U133A
|
286
|
Samsung Lung Cancer
|
Gene Expression Omnibus
|
GSE8894
|
HG-U133_Plus_2
|
138
|
Bild Lung Cancer
|
Gene Expression Omnibus
|
GSE3141
|
HG-U133_Plus_2
|
111
|
Neuroblastoma tumor
|
Gene Expression Omnibus
|
GSE3960
|
HG_U95Av2
|
102
|
Neoadjuvant Breast Cancer
|
Gene Expression Omnibus
|
GSE4779
|
U133_X3P
|
[65] 102e
|
Postmortem - normal
|
Gene Expression Omnibus
|
GSE3526
|
HG-U133_Plus_2
|
353
|
Human body index - normal
|
Gene Expression Omnibus
|
GSE7307
|
HG-U133_Plus_2
|
504 [677]f
|
-
aAffymetrix HT Human Genome U133A Array
-
bAffymetrix Human Genome U133 Plus 2.0
-
cAffymetrix Human Genome U133A
-
d270 out of 341 samples are tumor samples.
-
e65 out of 102 are ER-negative samples.
-
f504 out of 677 samples are normal samples.